Krawczyk P. Role of molecular examinations in qualification to first line treatment with erlotinib in NSCLC patients based on EUTARCstudy results. OncoReview [Internet]. 2013Mar.29 [cited 2024Nov.23];3(1(9):26-3. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/332